Gill, Robert
Liu, Ming
Sun, Guang
Furey, Andrew
Spector, Tim
Rahman, Proton
Zhai, Guangju
Funding for this research was provided by:
Canadian Institutes of Health Research (MOP192552, 132178, 143058, 153298, 175015)
Arthritis Research UK (18030)
Wellcome Trust
Medical Research Council
Versus Arthritis
Horizon 2020
Chronic Disease Research Foundation
Zoe Ltd
National Institute for Health and Care Research (NIHR) Clinical Research Network (CRN) and Biomedical Research Centre
The Research and Development Corporation of Newfoundland and Labrador (5404.1423.102)
The Memorial University of Newfoundland Medical Research Fund
Article History
Received: 22 September 2023
Accepted: 14 January 2024
First Online: 20 January 2024
Declarations
:
: Both NFOAS and CODING study were approved by the Health Research Ethics Authority of Newfoundland and Labrador (HREB; NFOAS—# 2011.311 & CODING—#10.33). The arcOGEN was approved by the Oxfordshire Research Ethics Committee with reference 07/H0606/150. Written informed consent was obtained from all participants.
: Not applicable.
: Author P.R. discloses they are a paid consultant for AbbVie, BMS, Eli Lilly, Janssen, Novartis, Pfizer, and UCB. Research support as a PI from AbbVie, Pfizer, Novartis, and Janssen. Payment or honoraria from AbbVie, BMS, Eli-Lilly, Jansen, Pfizer, Novartis, UCB. Leadership or fiduciary role in the Canadian Academy of Health Sciences and Canadian Council of Academies.Author G.Z. discloses payment or honoraria from The Canadian Rheumatology Society 2022 and 7th World Congress on Controversies, Debates & Consensus on Bone, Muscle & Joint Diseases 2019.All other authors have no financial conflict of interest to disclose.